US STOCKS-S&P 500, Dow end at record highs, boosted by healthcare

martes 18 de noviembre de 2014 17:50 GYT
 

* Biotech index up more than 2 pct

* U.S. producer inflation up but underlying trend muted

* Indexes up: Dow 0.2 pct, S&P 0.5 pct, Nasdaq 0.7 pct (Updates to close)

By Caroline Valetkevitch

NEW YORK, Nov 18 (Reuters) - The Dow and S&P 500 closed at record highs on Tuesday, lifted by further gains in healthcare shares and hopes for a stronger global economy.

The S&P 500 scored its fourth straight day of gains.

Actavis Plc, Gilead Sciences and other biotechs were among the biggest drivers, a day after Allergan agreed to be bought by Actavis. The Nasdaq biotech index rose 2.1 percent.

The S&P health care index added 1.6 percent. Shares of Actavis were up 8.7 percent at $269.60, helped by bullish analyst notes, while Gilead's stock rose 3.3 percent to $103.71 percent.

"A little bit of a risk trade is coming back on, and those are the areas for the M&A," said Uri Landesman, president of Platinum Partners in New York. "It's a very, very good environment to buy growth, so I don't quibble with the notion that there's going to be more M&A."   Continuación...